Fortrea vs ICON plc

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fortrea/iconplc

Category	Fortrea	ICON plc
Listed site	cro	cro
Summary	Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.	ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Clinical Imaging Core Lab	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Flow Cytometry Services Bioanalysis Translational Research Biomarker Assays Immunogenicity Assays (ADA / NAb) Ligand-Binding Bioanalysis (Large Molecule) LC-MS Bioanalysis (Small Molecule) Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services Companion Diagnostics Development Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine
Indications	Cardiovascular Metabolic Dermatology Infectious Disease Immunology Nephrology Neurology Oncology Ophthalmology Rare Disease Respiratory Women's Health Gastroenterology	Cardiovascular Neurology Immunology Oncology Infectious Disease Metabolic Rare Disease Women's Health Ophthalmology
Locations	Global operations, United States Headquarters, Durham, NC, United States Dallas, Dallas, TX, United States Daytona Beach, Daytona Beach, FL, United States Madison, Madison, WI, United States Sydney, Sydney, NSW, Australia Beijing, Beijing, China Chengdu, Chengdu, Sichuan, China Dalian, Dalian, Liaoning, China Guangzhou, Guangzhou, China Hangzhou, Hangzhou, Zhejiang, China Hong Kong, Hong Kong, China Nanjing, Nanjing, Jiangsu, China Shanghai, Shanghai, China Seoul, Seoul, South Korea Taipei, Taipei, Taiwan Tokyo, Tokyo, Japan Raanana, Raanana, Israel Istanbul, Istanbul, Turkey Bogotá, Bogotá, Colombia Buenos Aires, Buenos Aires, Argentina Lima, Lima, Peru Mexico City, Mexico City, CDMX, Mexico Santiago, Santiago, Chile São Paulo, São Paulo, SP, Brazil Centurion, Centurion, Gauteng, South Africa Clinical Research Unit, Dallas, TX, United States Clinical Research Unit, Daytona Beach, FL, United States Clinical Research Unit, Madison, WI, United States Office, São Paulo, SP, Brazil Office, Mexico City, CDMX, Mexico Office, Buenos Aires, Argentina Office, Santiago, Chile Office, Lima, Peru Office, Bogotá, Colombia Office, Centurion, Gauteng, South Africa Office, Sydney, NSW, Australia Office, Beijing, China Office, Shanghai, China Office, Guangzhou, China Office, Chengdu, Sichuan, China Office, Dalian, Liaoning, China Office, Hangzhou, Zhejiang, China Office, Nanjing, Jiangsu, China Office, Hong Kong, China Office, Tokyo, Japan Office, Seoul, South Korea Office, Taipei, Taiwan Office, Raanana, Israel Office, Istanbul, Turkey Office, Herzliya, Israel Herzliya, Raanana, Israel Herzliya, Herzliya, Israel Office, Hong Kong, Hong Kong	Headquarters, Dublin, Ireland Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico Belgium, Belgium, Belgium Bulgaria, Bulgaria, Bulgaria Germany, Germany, Germany Hungary, Hungary, Hungary Italy, Italy, Italy Netherlands, Netherlands, Netherlands Poland, Poland, Poland Romania, Romania, Romania Slovakia, Slovakia, Slovakia South Africa, South Africa, South Africa Spain, Spain, Spain Türkiye, Türkiye, Türkiye United Kingdom, United Kingdom, United Kingdom Australia, Australia, Australia China, China, China India, India, India Japan, Japan, Japan Korea, Korea, Korea Malaysia, Malaysia, Malaysia Taiwan, Taiwan, Taiwan Argentina, Argentina, Argentina Brazil, Brazil, Brazil Chile, Chile, Chile Colombia, Colombia, Colombia Mexico, Mexico, Mexico United States, United States, United States
Certifications	cGMP · Identifier: In-clinic cGMP Pharmacies FDA · Identifier: cGMP	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.